UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 311

Sortiert nach

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Hepatology (Baltimore, Md.), 2019-01, Vol.69 (1), p.394-419

2019

Link zum Volltext

Verfügbarkeit prüfen

Optimizing treatment of primary biliary cholangitis: Is good, good enough?

Hepatology (Baltimore, Md.), 2024-01, Vol.79 (1), p.3-5

2024

Link zum Volltext

Verfügbarkeit prüfen

Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases

Hepatology (Baltimore, Md.), 2022-04, Vol.75 (4), p.1012-1013

2022

Link zum Volltext

Verfügbarkeit prüfen

Primary biliary cirrhosis

The Lancet (British edition), 2011-05, Vol.377 (9777), p.1600-1609

2011

Link zum Volltext

Verfügbarkeit prüfen

Role of Antinuclear Antibodies in Primary Biliary Cholangitis

The American journal of gastroenterology, 2020-10, Vol.115 (10), p.1604-1606

2020

Link zum Volltext

Verfügbarkeit prüfen

Scratching the surface of cholestatic itch treatments

Hepatology (Baltimore, Md.), 2018-05, Vol.67 (5), p.2045-2048

Bowlus, Christopher L.

2018

Link zum Volltext

Verfügbarkeit prüfen

AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review

Clinical gastroenterology and hepatology, 2019-11, Vol.17 (12), p.2416-2422

2019

Link zum Volltext

Verfügbarkeit prüfen

AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma

Hepatology (Baltimore, Md.), 2023-02, Vol.77 (2), p.659-702

2023

Link zum Volltext

Verfügbarkeit prüfen

The diagnosis of primary biliary cirrhosis

Autoimmunity reviews, 2014-04, Vol.13 (4), p.441-444

2014

Link zum Volltext

Verfügbarkeit prüfen

Recent Advances in the Management of Primary Sclerosing Cholangitis

Clinical gastroenterology and hepatology, 2023-07, Vol.21 (8), p.2065-2075

2023

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies

Clinical gastroenterology and hepatology, 2022-08, Vol.20 (8), p.1687-1700.e4

2022

Link zum Volltext

Verfügbarkeit prüfen

Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process

Gastroenterology (New York, N.Y. 1943), 2021-12, Vol.161 (6), p.1764-1775.e5

2021

Link zum Volltext

Verfügbarkeit prüfen

A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis

Journal of hepatology, 2020-07, Vol.73 (1), p.94-101

2020

Link zum Volltext

Verfügbarkeit prüfen

The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis

Hepatology (Baltimore, Md.), 2019-09, Vol.70 (3), p.788-801

2019

Link zum Volltext

Verfügbarkeit prüfen

Reply to: “Seladelpar in patients with primary biliary cholangitis: Need for a closer look!”

Journal of hepatology, 2022-11, Vol.77 (5), p.1452-1453

2022

Link zum Volltext

Verfügbarkeit prüfen

Editorial: biochemical responses do not tell the whole story in primary biliary cholangitis

Alimentary pharmacology & therapeutics, 2020-01, Vol.51 (1), p.177-178

2020

Link zum Volltext

Verfügbarkeit prüfen

Editorial: The evolving paradigms and treatments for primary biliary cholangitis—Authors' reply

Alimentary pharmacology & therapeutics, 2024-01, Vol.59 (2), p.282-282

2024

Link zum Volltext

Verfügbarkeit prüfen

IL‐12/Th1 and IL‐23/Th17 biliary microenvironment in primary biliary cirrhosis: Implications for therapy

Hepatology (Baltimore, Md.), 2014-05, Vol.59 (5), p.1944-1953

2014

Link zum Volltext

Verfügbarkeit prüfen

Autoimmune Markers in Primary Biliary Cholangitis

Clinics in liver disease, 2024-02, Vol.28 (1), p.93-101

2024

Link zum Volltext

Verfügbarkeit prüfen

Application of the Latest Advances in Evidence-Based Medicine in Primary Biliary Cholangitis

The American journal of gastroenterology, 2023-02, Vol.118 (2), p.232-242

2023

Link zum Volltext

Verfügbarkeit prüfen

The geoepidemiology of autoimmune intestinal diseases

Autoimmunity reviews, 2010-03, Vol.9 (5), p.A372-A378

2010

Link zum Volltext

Verfügbarkeit prüfen

The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population

BMC gastroenterology, 2011-07, Vol.11 (1), p.83-83, Article 83

2011

Link zum Volltext

Verfügbarkeit prüfen

Etiopathogenesis of autoimmune hepatitis

Journal of autoimmunity, 2018-12, Vol.95, p.133-143

2018

Link zum Volltext

Verfügbarkeit prüfen

Reply: Living donor liver transplantation for people with PSC

Hepatology (Baltimore, Md.), 2023-05, Vol.77 (5), p.E97-E98

2023

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Primary Biliary Cholangitis: First-Line and Second-Line Therapies

Clinics in liver disease, 2022-11, Vol.26 (4), p.705-726

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 311

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(289)
Mit Volltextzugriff
(273)

Publikationsform

Artikel
(293)
Buchkapitel
(18)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Optimizing treatment of primary biliary cholangitis: Is good, good enough?

Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases

Primary biliary cirrhosis

Role of Antinuclear Antibodies in Primary Biliary Cholangitis

Scratching the surface of cholestatic itch treatments

AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review

AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma

The diagnosis of primary biliary cirrhosis

Recent Advances in the Management of Primary Sclerosing Cholangitis

Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies

Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process

A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis

The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis

Reply to: “Seladelpar in patients with primary biliary cholangitis: Need for a closer look!”

Editorial: biochemical responses do not tell the whole story in primary biliary cholangitis

Editorial: The evolving paradigms and treatments for primary biliary cholangitis—Authors' reply

IL‐12/Th1 and IL‐23/Th17 biliary microenvironment in primary biliary cirrhosis: Implications for therapy

Autoimmune Markers in Primary Biliary Cholangitis

Application of the Latest Advances in Evidence-Based Medicine in Primary Biliary Cholangitis

The geoepidemiology of autoimmune intestinal diseases

The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population

Etiopathogenesis of autoimmune hepatitis

Reply: Living donor liver transplantation for people with PSC

Treatment of Primary Biliary Cholangitis: First-Line and Second-Line Therapies

Suchergebnisse filtern